Failure of cdc2 promoter activation and G2/M transition by ANG II and AVP in vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Fujita, Nobuya ^a   Furukawa, Yusuke ^a   Itabashi, Naoki ^a   Tsuboi, Yasushi ^a   Matsuda, Michio ^a   Okada, Koji ^a   Saito, Toshikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell cycle; Cyclin; E2F 1; Proliferating cell nuclear antigen

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; CELL CYCLE PROTEIN; CYCLIN B; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; MESSENGER RNA; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; GENE ACTIVATION; HYPERPLASIA; MALE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0032884303     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.2.h515     Document Type: Article

References (51)

1. Abe, J., W. Zhou, J. Taguchi, N. Takuwa, K. Miki, H. Okazaki, K. Kurokawa, M. Kumada, and Y. Takuwa. Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery. Biochem. Biophys. Res. Commun. 198: 16-24, 1994.
2. Berk, B. C., V. Vekshtein, H. M. Gordon, and T. Tsuda. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13: 305-314, 1989.
3. Born, T. L., J. A. Frost, A. Schonthal, G. C. Prendergast, and J. R. Feramisco. c-Myc cooperates with activated Ras to induce the cdc2 promoter. Mol. Cell. Biol. 14: 5710-5718, 1994.
4. Chang, M. W., E. Barr, M.-M. Lu, K. Barton, and J. M. Leiden. Adenovirus-mediated over-expression of the cyclin/ cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96: 2260-2268, 1995.
5. KIP1, an inhibitor of neointima formation in the rat carotid artery. J. Clin. Invest. 99: 2334-2341, 1997.
6. Daemen, M. J. A. P., D. M. Lombardi, F. T. Bosman, and S. M. Schwartz. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 68: 450-456, 1991.
7. Dalton, S. Cell cycle regulation of the human cdc2 gene. EMBO J. 11: 1797-1804, 1992.
8. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489, 1983.
9. Dunphy, W. G., L. Brizuela, D. Beach, and J. Newport. The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell 54: 423-431, 1988.
10. Furukawa, Y. Cell cycle regulation of hematopoietic stem cells. Hum. Cell 11: 81-92, 1998.
11. Furukawa, Y., S. Iwase, Y. Terui, J. Kikuchi, T. Sakai, M. Nakamura, S. Kitagawa, and M. Kitagawa. Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells. J. Biol. Chem. 271: 28469-28477, 1996.
12. Furukawa, Y., Y. Terui, K. Sakoe, M. Ohta, and M. Saito. The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells. J. Biol. Chem. 269: 26249-26258, 1994.
13. +. Cell 54: 433-439, 1988.
14. Geisterfer, A. A. T., M. J. Peach, and G. K. Owens. Angiotensin II induces hypertrophy not hyperplasia of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749-756, 1988.
15. Girard, F., U. Strausfeld, A. Fernandez, and N. J. C. Lamb. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67: 1169-1179, 1991.
16. Gorman, C. M., L. F. Moffat, and B. H. Howard. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051, 1982.
17. Granot, Y., E. Erikson, H. Fridman, V. Van Putten, B. Williams, R. W. Schrier, and J. L. Mailer. Direct evidence for tyrosine and threonine phosphorylatiori and activation of mitogen-activated protein kinase by vasopressin in cultured rat vascular smooth muscle cells. J. Biol. Chem. 268: 9564-9569, 1993.
18. Guo, X., K. Okada, N. Fujita, S. Ishikawa, N. Komatsu, and T. Saito. Inhibitory effect of BQ-123 on endothelin-1-stimulated mitogen-activated protein kinase and cell growth of rat vascular smooth muscle cells. Hypertens. Res. 19: 23-30, 1996.
19. Iwase, S., Y. Furukawa, J. Kikuchi, M. Nagai, Y. Terui, M. Nakamura, and H. Yamada. Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells. J. Biol. Chem. 272: 12406-12414, 1997.
20. Jackson, C. L., and S. M. Schwartz. Pharmacology of smooth muscle cell replication. Hypertension 20: 713-736, 1992.
21. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7: 331-342, 1993.
22. Kitagawa, M., T. Okabe, H. Ogino, H. Matsumoto, I. Suzuki-Takahashi, T. Kokubo, H. Higashi, S. Saitoh, Y. Taya, H. Yasuda, Y. Ohba, S. Nishimura, N. Tanaka, and A. Okuyama. Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. Oncogene 8: 2425-2432, 1993.
23. Ku, D.-H., S.-C. Wen, A. Engelhard, N. C. Nicolaides, K. E. Lipson, T. A. Marino, and B. Calabretta. c-myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene. J. Biol. Chem. 268: 2255-2259, 1993.
24. cdc2 gene by cdc2 promoter binding factor/nuclear factor-Y in fetal rat ventricular myocytes. Circ. Res. 82: 251-260, 1998.
25. cdc2: in vivo veritas? Cell 61: 549-551, 1990.
26. Morgan, D. O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Ann. Rev. Cell Dev. Biol. 13: 261-291, 1997.
27. Morishita, R., G. H. Gibbons, K. E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA 90: 8474-8478, 1993.
28. Naftilan, A. J., R. E. Pratt, and V. J. Dzau. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1419-1424, 1989.
29. Newby, A. C., and S. J. George. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc. Res. 27: 1173-1183, 1993.
30. 1 in mammalian fibroblasts. Science 259: 1908-1912, 1993.
31. +-adenosine triphosphate on vascular action of vasopressin. J. Clin. Invest. 86: 1241-1248, 1990.
32. Okada, K., S. Ishikawa, and T. Saito. Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 178: 707-712, 1991.
33. + in vascular smooth muscle cells. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F1007-F1012, 1991.
34. Okada, K., R. Sasaki, S. Ishikawa, and T. Saito. Distinct inhibition by non-peptide and peptide arginine vasopressin antagonists of vasopressin-induced activation of mitogen-activated protein kinase in cultured rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 200: 1155-1160, 1994.
35. Onishi, T., W. Zhang, X. Cao, and K. Hruska. The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors. J. Bone Miner. Res. 12: 1596-605, 1997.
36. Powell, J. S., J.-P. Clozel, R. K. M. Mullar, H. Kuhn, F. Hefti, M. Hosang, and H. R. Baumgartner. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186-188, 1989.
37. Sachinidis, A., Y. Ko, W. Nettekoven, A. J. Wieczorek, R. Dusing, and H. Vetter. The effect of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wister-Kyoto rats. J. Hypertens. 10: 1159-1164, 1992.
38. Sadoshima, J., H. Aoki, and S. Izumo. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ. Res. 80: 228-241, 1997.
39. c-src. J. Biol. Chem. 271: 10329-10333, 1996.
40. Seed, B., and J.-Y. Sheen. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67: 271-277, 1988.
41. 1/S boundary-specific enhancer of the rat cdc2 promoter. Mol. Cell. Biol. 15: 2882-2892, 1995.
42. Spurr, N. K., A. C. Gough, and M. G. Lee. Cloning of the mouse homologue of the yeast cell cycle control gene cdc2. DNA Seq. 1: 49-54, 1990.
43. Sugarman, J. L., A. H. Schonthal, and C. K. Glass. Identification of a cell-type-specific and E2F-independent mechanism for repression of cdc2 transcription. Mol. Cell. Biol. 15: 3282-3290, 1995.
44. Thatcher, J. D., B. McBride, and K. S. Katula. Promoter binding factors regulating cyclin B transcription in the sea urchin embryo. DNA Cell Biol. 14: 869-881, 1995.
45. Tommasi, S., and G. P. Pfeifer. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15: 6901-6913, 1995.
46. 1 by the silencer element. Cell Growth Differ. 9: 257-265, 1998.
47. Watanabe, G., R. J. Lee, C. Albanese, W. E. Rainey, D. Batlle, and R. G. Pestell. Angiotensin II activation of cyclin D1-dependent kinase activity. J. Biol. Chem. 271: 22570-22577, 1996.
48. cdc2 and mitogen-activated protein kinase homologues. Circ. Res. 73: 109-117, 1993.
49. Wen, S.-C., D.-H. Ku, A. De Luca, P. P. Claudio, A. Giordano, and B. Calabretta. Ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A. Exp. Cell Res. 217: 8-14, 1995.
50. cdc2 expression and normal p53 suppresses cyclin A expression. Exp. Cell Res. 210: 94-101, 1994.
51. Zwicker, J., F. C. Lucibello, L. A. Wolfraim, C. Gross, M. Truss, K. Engeland, and R. Müller. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanisms of transcriptional repression. EMBO J. 14: 4514-4522, 1995.